Pathogenesis of leukoencephalopathies in HIV+ patients

HIV患者白质脑病的发病机制

基本信息

  • 批准号:
    7626425
  • 负责人:
  • 金额:
    $ 23.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-01 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The use of more intensive antiretroviral therapies, such as HAART, in the treatment of HIV infection has led to a marked reduction in morbidity and mortality associated with AIDS. This happens because the incidence of the major opportunistic infections and of many AIDS-related neurological disorders dramatically decreased, but the Progressive Multifocal Leukoencephalopathy (PML) is still observed with a prevalence up to 5% in AIDS patients. Although the advent of HAART did not affect so much the incidence of PML, some changes in the clinical course of this fatal disease have been observed. In fact PML usually results in death within 3-6 months of diagnosis (PML fast progressing patients), but to date there are reports of remission of PML during HAART and several PML cases have prolonged rate of survival, up to one year from the onset of the disease (PML slow progressing patients). In this project we are hypothesizing that either a particular JCV genotype or a specific TCR rearrangement or both could affect the disease progress, slowing down the process of demyelination. Moreover several cases suffering with a PML-like Leukoencephalopathy, called non- determined Leukoencephalopathy (NDLE) with no evidence of JCV genome in CSF have been lately reported. Our suggestion is that the result of an improved immune status upon HAART could also lead to an imbalanced expression of cytokines and immunomodulators by peripheral lymphocytes that may affect. In order to verify our hypothesis and better understand the etiology, the development and the progress of the new variant of PML and of the novel JCV negative-leukoencephalopathy, we are proposing to enroll in a longitudinal study, patients affected with fast and slow progressing PML, patients with suspected NDLE, HIV+ patients without any neurological disorders and healthy controls, whose biological samples will be collected at different times of the diseases and subjected to immunological, virological, genetic conventional and innovative examinations as described in the proposal.
描述(由申请人提供):使用更密集的抗逆转录病毒疗法(例如HAART)在艾滋病毒感染治疗中的使用导致与艾滋病相关的发病率和死亡率显着降低。之所以发生这种情况,是因为主要的机会性感染和许多与AIDS相关的神经系统疾病的发生率显着降低,但是在AIDS患者中,进行性多灶性白细胞厌氧(PML)仍被观察到高达5%的患病率。尽管HAART的出现并没有太大影响PML的发病率,但已经观察到这种致命疾病的临床病程的某些变化。实际上,PML通常会在诊断后的3-6个月内导致死亡(PML快速进展患者),但迄今为止,有报道称HAART期间PML缓解,几例PML病例的生存率延长,从疾病发作后长达一年(PML缓慢进展的患者)。在这个项目中,我们假设特定的JCV基因型或特定的TCR重排或两者都可能影响疾病进展,从而减慢脱髓鞘的过程。此外,最近有几例患有PML样的白细胞脑病,称为非确定的白细胞脑病(NDLE),而CSF中没有JCV基因组的证据。我们的建议是,HAART上的免疫状态改善的结果也可能导致可能影响的周围淋巴细胞对细胞因子和免疫调节剂的表达不平衡。 In order to verify our hypothesis and better understand the etiology, the development and the progress of the new variant of PML and of the novel JCV negative-leukoencephalopathy, we are proposing to enroll in a longitudinal study, patients affected with fast and slow progressing PML, patients with suspected NDLE, HIV+ patients without any neurological disorders and healthy controls, whose biological samples will be collected at different times of the diseases and如该提案所述,接受免疫,病毒学,遗传常规和创新性检查。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases.
  • DOI:
    10.1016/j.clim.2008.08.010
  • 发表时间:
    2008-12
  • 期刊:
  • 影响因子:
    8.6
  • 作者:
    Saresella, Marina;Marventano, Ivana;Guerini, Franca Rosa;Zanzottera, Milena;Delbue, Serena;Marchioni, Enrico;Maserati, Renato;Longhi, Renato;Ferrante, Pasquale;Clerici, Mario
  • 通讯作者:
    Clerici, Mario
JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.
  • DOI:
    10.1080/13550280802425467
  • 发表时间:
    2009-01
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Delbue S;Branchetti E;Bertolacci S;Tavazzi E;Marchioni E;Maserati R;Minnucci G;Tremolada S;Vago G;Ferrante P
  • 通讯作者:
    Ferrante P
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma.
  • DOI:
    10.1002/jmv.21322
  • 发表时间:
    2008-12
  • 期刊:
  • 影响因子:
    12.7
  • 作者:
    Mancuso, Roberta;Biffi, Renato;Valli, Marilena;Bellinvia, Monica;Athanasia, Tourlaki;Ferrucci, Silvia;Brambilla, Lucia;Delbue, Serena;Ferrante, Pasquale;Tinelli, Carmine;Clerici, Mario
  • 通讯作者:
    Clerici, Mario
Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus.
急性播散性脑脊髓炎研究的招募标准:需要达成共识。
Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient.
  • DOI:
    10.1007/s10072-008-0982-6
  • 发表时间:
    2008-09
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Tavazzi, Eleonora;Minoli, Lorenzo;Ferrante, Pasquale;Scagnelli, Paola;Del Bue, Serena;Romani, Alfredo;Ravaglia, Sabrina;Marchioni, Enrico
  • 通讯作者:
    Marchioni, Enrico
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PASQUALE FERRANTE其他文献

PASQUALE FERRANTE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PASQUALE FERRANTE', 18)}}的其他基金

Pathogenesis of leukoencephalopathies in HIV+ patients
HIV患者白质脑病的发病机制
  • 批准号:
    7072721
  • 财政年份:
    2005
  • 资助金额:
    $ 23.04万
  • 项目类别:
Pathogenesis of leukoencephalopathies in HIV+ patients
HIV患者白质脑病的发病机制
  • 批准号:
    7424967
  • 财政年份:
    2005
  • 资助金额:
    $ 23.04万
  • 项目类别:
Pathogenesis of leukoencephalopathies in HIV+ patients
HIV患者白质脑病的发病机制
  • 批准号:
    7492555
  • 财政年份:
    2005
  • 资助金额:
    $ 23.04万
  • 项目类别:
Pathogenesis of leukoencephalopathies in HIV+ patients
HIV患者白质脑病的发病机制
  • 批准号:
    6893177
  • 财政年份:
    2005
  • 资助金额:
    $ 23.04万
  • 项目类别:
Leukoencephalopathy in HAART-treated HIV-1+ Patients
HAART 治疗的 HIV-1 患者的白质脑病
  • 批准号:
    6743137
  • 财政年份:
    2003
  • 资助金额:
    $ 23.04万
  • 项目类别:
Leukoencephalopathy in HAART-treated HIV-1+ Patients
HAART 治疗的 HIV-1 患者的白质脑病
  • 批准号:
    6656763
  • 财政年份:
    2003
  • 资助金额:
    $ 23.04万
  • 项目类别:

相似国自然基金

多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
  • 批准号:
    82373667
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
  • 批准号:
    12303035
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
  • 批准号:
    12301629
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
  • 批准号:
    82304205
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
  • 批准号:
    42305193
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Applying Deep Learning for Predicting Retention in PrEP Care and Effective PrEP Use among Key Populations at Risk for HIV in Thailand
应用深度学习预测泰国主要艾滋病毒高危人群中 PrEP 护理的保留情况以及 PrEP 的有效使用
  • 批准号:
    10619943
  • 财政年份:
    2023
  • 资助金额:
    $ 23.04万
  • 项目类别:
Multi-Omics Predictors of Oral HPV Outcomes among PLWH
PLWH 口腔 HPV 结果的多组学预测
  • 批准号:
    10557585
  • 财政年份:
    2023
  • 资助金额:
    $ 23.04万
  • 项目类别:
Improving Healthcare Quality and Equity For Older Adults with HIV Under Value-Based Care Models
在基于价值的护理模式下提高艾滋病毒感染者的医疗质量和公平性
  • 批准号:
    10762522
  • 财政年份:
    2023
  • 资助金额:
    $ 23.04万
  • 项目类别:
Assessing the Impact of Economic Policies on the Use of Pre-Exposure Prophylaxis in the United States
评估经济政策对美国使用暴露前预防的影响
  • 批准号:
    10698785
  • 财政年份:
    2023
  • 资助金额:
    $ 23.04万
  • 项目类别:
Bridges2Scale: Testing implementation strategies for an intervention among young people affected by AIDS
Bridges2Scale:测试对受艾滋病影响的年轻人进行干预的实施策略
  • 批准号:
    10713990
  • 财政年份:
    2023
  • 资助金额:
    $ 23.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了